Medicare Enrolled

Dr. Tanmay Panchabhai, MD

Pulmonary Disease · Cleveland, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
11100 EUCLID AVE, Cleveland, OH 44106
2016844850
Registered in NPPES since 2009
NPI: 1578899027 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Panchabhai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Panchabhai? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Panchabhai

Dr. Tanmay Panchabhai is a pulmonary disease specialist in Cleveland, OH, with 16 years of NPI registration. Based on federal Medicare data, Dr. Panchabhai performed 276 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Panchabhai received a total of $35,766 from 32 pharmaceutical and/or device companies across 151 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Panchabhai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years of NPI registration ▲ 276 Medicare services $35,766 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
276
Medicare services
Bottom 22% in OH for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
39 $61 $176
Bronchial secretion aspiration via endoscope
Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus.
30 $31 $615
Bronchoscopy with ultrasound and lymph node sampling
A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes.
28 $116 $901
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
27 $85 $291
New patient office visit, complex (60-74 min) 26 $188 $626
Endoscopic needle biopsy of windpipe, airway, or lung
A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung.
24 $119 $843
Bronchoscopy with ultrasound and growth treatment
A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found.
24 $54 $266
Computer-assisted navigation of lung airways
This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation.
23 $78 $362
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
22 $170 $821
Lung biopsy via endoscope, 1 lobe
A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination.
19 $33 $725
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
14 $124 $442
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$35,766
Total received (2018-2024)
Avg $5,109/year across 7 years
Top 8% in OH for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
151
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,096
2023
$175
2022
$433
2021
$796
2020
$6,926
2019
$8,239
2018
$16,102

Payments by company (2024)

INTUITIVE SURGICAL, INC.
$2,556
AstraZeneca Pharmaceuticals LP
$525
Pulmonx Corporation
$14
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$15,580
Boehringer Ingelheim Pharmaceuticals, Inc.
$7,635
Intuitive Surgical, Inc.
$3,047
INTUITIVE SURGICAL, INC.
$2,556
Veran Medical Technologies, Inc.
$2,018
Covidien LP
$1,451
Ethicon Inc.
$1,001
AstraZeneca Pharmaceuticals LP
$539
Astellas Pharma US Inc
$494
Allergan Inc.
$457
Merck Sharp & Dohme Corporation
$134
Insmed, Inc.
$107
Pinnacle Biologics, Inc
$95
Bard Peripheral Vascular, Inc.
$87
Pulmonx Corporation
$75
Davol Inc.
$63
PORTOLA PHARMACEUTICALS, INC.
$63
United Therapeutics Corporation
$56
Harmony Biosciences LLC
$41
Grifols USA, LLC
$37
Eurofins Viracor, Inc.
$32
Philips Electronics North America Corporation
$28
KARL STORZ Endoscopy-America
$24
Genentech USA, Inc.
$19
Shire North American Group Inc
$18
Amgen Inc.
$17
Ambu Inc.
$17
Alexion Pharmaceuticals, Inc.
$17
PFIZER INC.
$16
AbbVie, Inc.
$16
Sobi, Inc
$13
E.R. Squibb & Sons, L.L.C.
$12
Top 3 companies account for 73.4% of all-time payments
Associated products mentioned in payments ›
AMBISOME · ANDEXXA · AVYCAZ · Arikayce · BEVYXXA · CHARTIS CATHETER · CRESEMBA · Creon · DIFICID · Da Vinci Surgical System · ELIQUIS · EVENITY · EXPECT · Esbriet · GENERAL BILIARY DEVICES · GENERAL THERAPIES · GENERAL - BILIARY DEVICES · GENERAL - THERAPIES · GENERAL PULMONARY · GLASSIA · HOPKINS · IMFINZI · KINERET · Monarch Platform · OFEV · ORENITRAM · PREVNAR - 13 · Photofrin · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · S&RC Und · Spin · Strensiq · SuperDimension · TAGRISSO · TYVASO · ULTRAFLEX · WAKIX · Wakix · ZERBAXA · superDimension
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pulmonary disease specialist in Cleveland?
Compare pulmonary diseases in the Cleveland area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases in nearby ZIP areas
53
County median income
$62,823
Nearest hospital to ZIP centroid (approximate)
LOUIS STOKES CLEVELAND VA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Panchabhai is a mixed practice specialist, with moderate Medicare volume, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Panchabhai experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Panchabhai performed 39 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Panchabhai receive payments from pharmaceutical companies?
Yes. Dr. Panchabhai received a total of $35,766 from 32 companies across 151 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Panchabhai's costs compare to other pulmonary diseases in Cleveland?
Dr. Panchabhai's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Panchabhai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →